Abstract
High-throughput molecular profiling has revolutionized our understanding of molecular mechanisms involved in disease progression and treatment response. As more information from patients' high-throughput molecular and clinical profiles (i.e., Big Data) becomes accessible, there is a significant shift in personalized and precision-based patient-centric approaches, allowing for an individualized therapeutic planning and more accurate prediction of therapeutic success or failure. Here, we discuss the most commonly utilized Big Data types (touching on most recent advances), including genome, DNA methylome, and transcriptome (i.e., RNA abundance and alternative splicing), alongside computational methods for their effective analysis. Further, we discuss how Big Data integration helps in unveiling complex molecular relationships involved in treatment response in oncology, including identification of biological pathways as markers of treatment resistance, and how its utilization builds a foundation for improved clinical decision making and precision medicine.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
